FEDERATED HERMES, INC. - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 143 filers reported holding IMMUNITYBIO INC in Q4 2021. The put-call ratio across all filers is 4.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$439
-99.0%
260
-98.3%
0.00%
Q2 2023$43,799
+9.4%
15,755
-28.4%
0.00%
Q1 2023$40,053
+264.1%
22,007
+1001.5%
0.00%
Q1 2022$11,000
-8.3%
1,998
+0.2%
0.00%
Q4 2021$12,000
-72.7%
1,995
-55.9%
0.00%
Q3 2021$44,000
-32.3%
4,524
-0.7%
0.00%
Q2 2021$65,000
+3150.0%
4,558
+4854.3%
0.00%
Q1 2021$2,000920.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders